Please provide your email address to receive an email when new articles are posted on . In this video, Robert DeBernardo, MD, shares insight on antibody-drug conjugates as treatment for patients with ...
Solve Therapeutics Inc. has identified antibody-drug conjugates comprising an UC-961 antibody or a tyrosine-protein kinase transmembrane receptor ROR2 (ROR2)-targeting antibody covalently linked to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results